Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 2021. Start Trial.
Date Value
October 14, 2026 0.9894
October 13, 2026 1.052
October 12, 2026 1.096
October 09, 2026 1.174
October 08, 2026 1.140
October 07, 2026 1.186
October 06, 2026 1.313
October 05, 2026 1.366
October 02, 2026 1.338
October 01, 2026 1.329
September 30, 2026 1.416
September 29, 2026 1.384
September 28, 2026 1.546
September 25, 2026 1.521
September 24, 2026 1.487
September 23, 2026 1.503
September 22, 2026 1.569
September 21, 2026 1.660
September 18, 2026 1.229
September 17, 2026 1.215
September 16, 2026 1.311
September 15, 2026 1.351
September 14, 2026 1.452
September 11, 2026 1.279
September 10, 2026 1.263
Date Value
September 09, 2026 1.298
September 08, 2026 1.344
September 04, 2026 1.344
September 03, 2026 1.359
September 02, 2026 1.309
September 01, 2026 1.432
August 31, 2026 1.554
August 28, 2026 1.57
August 27, 2026 1.465
August 26, 2026 1.468
August 25, 2026 1.528
August 24, 2026 1.534
August 21, 2026 1.622
August 20, 2026 1.548
August 19, 2026 1.562
August 18, 2026 1.413
August 17, 2026 1.205
August 14, 2026 1.174
August 13, 2026 1.116
August 12, 2026 1.192
August 11, 2026 1.119
August 10, 2026 1.096
August 07, 2026 1.204
August 06, 2026 1.073
August 05, 2026 0.9838

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 20.07
Anika Therapeutics, Inc. 2.019
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.170

Price to Book Value Related Metrics

PS Ratio 3.076
Price 0.6636
Earnings Yield -56.21%
Market Cap 195.60M